Tutorials
Endologix Inc logo

Endologix Inc

$ 0.02 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 410.00K
Enterprise V:
$ 410.00K
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
410.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
410.00K
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Endologix Inc
NAICS : 339112 SIC : 3841
2 Musick, Irvine, CA, USA, 92618
Description
Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms such as AFX Endovascular AAA System, VELA Proximal Endograft, and Ovation Abdominal Stent Graft System. The firm generates the majority of its revenue in the United States.

Financial Strength

Name Current Vs Industry Vs History
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -92.54
12-1 Month Momentum % -98.49

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

ELGXQ's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:ELGXQ

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 124.877
EPS (TTM) ($) -2.96
Beta 0
Volatility % 76.5
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % -98.49
52-Week Range ($) 0.01 - 3.96
Shares Outstanding (Mil) 20.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Endologix Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More